Redox Reactivity of Modified Hemoglobins with Hydrogen Peroxide and Nitric Oxide: Toxicological Implications.

Autor: Alayash, A. I., Brockner Ryan, B. A., Fratantoni, J. C., Cashon, R. E.

Publikováno v: Artificial Cells, Blood Substitutes & Biotechnology; 1994, Vol. 22 Issue 3, p373-386, 14p

A putative glutathione-binding site in CdZn-metallothionein identified by equilibrium binding and molecular-modelling studies

Autor: Brouwer, M, Hoexum-Brouwer, T, Cashon, R E

Publikováno v: Biochemical Journal; August 1993, Vol. 294 Issue: 1 p219-225, 7p

Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes.

Autor: Hrinczenko BW; Laboratory of Chemical Biology and Structural Mass Spectroscopy Group, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892, USA., Schechter AN, Wojtkowski TL, Pannell LK, Cashon RE, Alayash AI

Publikováno v: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2000 Sep 07; Vol. 275 (3), pp. 962-7.

Peroxynitrite-mediated heme oxidation and protein modification of native and chemically modified hemoglobins.

Autor: Alayash AI; Laboratory of Cellular Hematology, Food and Drug Administration, Bethesda, Maryland 20892, USA. Alayash@A1.cber.fda.gov, Ryan BA, Cashon RE

Publikováno v: Archives of biochemistry and biophysics [Arch Biochem Biophys] 1998 Jan 01; Vol. 349 (1), pp. 65-73.

Hemoglobin and free radicals: implications for the development of a safe blood substitute.

Autor: Alayash AI; Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA. Alayash@A1.CBER.FDA.GOV, Cashon RE

Publikováno v: Molecular medicine today [Mol Med Today] 1995 Jun; Vol. 1 (3), pp. 122-7.